Structure Therapeutics Inc (GPCR)
32.00
+1.90
(+6.31%)
USD |
NASDAQ |
Nov 22, 11:07
Structure Therapeutics Total Assets (Quarterly): 933.22M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 933.22M |
| June 30, 2024 | 947.03M |
| March 31, 2024 | 457.22M |
| December 31, 2023 | 482.02M |
| September 30, 2023 | 216.37M |
| Date | Value |
|---|---|
| June 30, 2023 | 229.43M |
| March 31, 2023 | 247.35M |
| December 31, 2022 | 97.84M |
| September 30, 2022 | 108.41M |
| December 31, 2021 | 111.16M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
97.84M
Minimum
Dec 2022
947.03M
Maximum
Jun 2024
383.00M
Average
238.39M
Median
Total Assets (Quarterly) Benchmarks
| Viking Therapeutics Inc | 937.89M |
| Eli Lilly and Co | 75.61B |
| Novo Nordisk AS | 59.53B |
| Pfizer Inc | 219.48B |
| Amgen Inc | 90.88B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 36.42M |
| Shareholders Equity (Quarterly) | 896.80M |